
Standard of care chemoradiation for stage III NSCLC is superior to two tested alternatives
Lung cancer is the leading cause of cancer death in the United States and approximately…
Lung cancer is the leading cause of cancer death in the United States and approximately…
Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered…
Findings from a Polish phase III study point to an additional treatment option for patients…